United Therapeutics sues Liquidia and ex-employee over YUTREPIA IP misappropriation

Liquidia Corp

Complaint filed May 29, 2024 in Durham County, NC, against former employee and Liquidia subsidiary.
Alleges breach of employment agreements and misappropriation of IP leading to YUTREPIA (treprostinil) inhalation powder.
United Therapeutics seeks assignment of patents and declaratory relief that inventions belong to them.
Liquidia intends to vigorously defend against the allegations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.